Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Anadrol and Ara 290 Interaction: Monitor | Peptide Database

Compound Profiles Anadrol Oral Anabolic Steroid | Extreme Mass & Strength Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it ca

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Anadrol

Oral Anabolic Steroid | Extreme Mass & Strength

Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme.

Ara 290

Tissue-Protective Peptide | Innate Repair Receptor Agonist

Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Anadrol with Ara 290?

Yes, but with caution. Both Anadrol and Ara 290 can elevate hematocrit/RBC count. Combined use increases risk of polycythemia and thrombotic events. Monitor CBC regularly — donate blood if hematocrit exceeds 54%. Regular monitoring is advised.

Is Anadrol and Ara 290 safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: hematocrit raising, teratogenic. Monitor accordingly.

What are the interactions between Anadrol and Ara 290?

Both Anadrol and Ara 290 can elevate hematocrit/RBC count. Combined use increases risk of polycythemia and thrombotic events. Monitor CBC regularly — donate blood if hematocrit exceeds 54%. This assessment has 65% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anadrol and Ara 290?

Anadrol has a half-life of ~8-9 hours and Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Primary mechanism activating dormant muscle satellite cells which fuse to damaged fibers. Increases proliferative lifespan in younger muscle progenitor cells. Increases activated satellite cell fusion capacity supporting repair and hypertrophy. Animal studies suggest improved Achilles tendon injury outcomes. Rabbit models demonstrated faster healing via osteoblast regulation. Research indicates potential for articular cartilage injury models. Naturally upregulated after mechanical stress; supplementation may enhance processes. Localized injection near injury sites supports targeted tissue repair.

Source: peptide-db.com ↗

Community Research

Join others researching PNC-27 — share findings, ask questions, and learn from real experiences PNC-27 is an experimental anti-cancer peptide created by a supercomputer at SUNY Downstate Medical Center in 2000. It contains an HDM-2 binding domain from p53 (residues 12-26) linked to a cell-penetrating domain. The peptide selectively kills cancer cells by binding to HDM-2 (MDM2) expressed on cancer cell membranes, forming pores that cause cell necrosis. Critically, PNC-27 has no effect on normal cells because healthy cells don't express HDM-2 on their membranes. Research shows effectiveness against pancreatic cancer, breast cancer, leukemia, and melanoma. PNC-27 exploits a unique vulnerability of cancer cells: the presence of HDM-2 (human double minute 2, also called MDM2) on their cell surface. The peptide's p53 residues adopt a conformation that binds directly to membrane-bound HDM-2, inducing transmembrane pore formation. This causes rapid tumor cell necrosis (not apoptosis). Additionally, PNC-27 enters cancer cells and disrupts mitochondrial membranes. Normal cells lack surface HDM-2 expression and are completely spared.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Available in capsule form for oral administration. As a tripeptide, Ovagen is transported via PEPT1/PEPT2 transporters for targeted delivery to liver and GI tissue. Typical protocol involves 10-20 day cycles. Standard protocol 10-20 mg Daily for 10-20 days Oral capsules Maintenance 10 mg 2-3 cycles yearly

Source: peptide-db.com ↗
Side effects

Will tamoxifen cause hot flashes and other side effects during PCT?

Yes—hot flashes are common during the first 2-4 weeks as your estrogen and testosterone levels normalize. These typically resolve once hormones stabilize. Other common side effects include mood swings and mild nausea. These are temporary PCT-phase effects that disappear once recovery is complete.

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides